Form 4: Eli Lilly Executive Acquires Shares and Restricted Stock Units
SEC Form 4 Filing
An Eli Lilly executive, Alonzo Weems, acquired 951 shares of common stock and 980 restricted stock units on February 12, 2024.
Summary
- Alonzo Weems, an Executive Vice President at Eli Lilly, reported a transaction on February 12, 2024.
- The transaction involved the acquisition of 951 shares of Eli Lilly common stock at a price of $737.26 per share.
- Additionally, Mr. Weems acquired 980 restricted stock units, each representing a contingent right to receive one share of Eli Lilly common stock.
- These restricted stock units are set to vest on February 1, 2025.
- Following these transactions, Mr. Weems directly owns 7,951 shares of Eli Lilly common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction by an executive, which is generally viewed positively as it indicates confidence in the company. However, it's not a major event that would drastically alter sentiment.
Positives
- The acquisition of shares by an executive can be seen as a positive sign of confidence in the company's future.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's performance and future prospects.
Comparison to Industry Standards
- Executive stock transactions are a standard practice across publicly listed companies, including pharmaceutical giants like Pfizer, Johnson & Johnson, and Merck.
- These transactions are typically disclosed through SEC filings like Form 4, ensuring transparency and compliance with regulations.
- The size and frequency of these transactions can vary based on company policies and individual executive compensation packages.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment, reflecting executive confidence.
Key Dates
| Date | Description |
|---|---|
| 02/12/2024 | Date of the transaction where shares and restricted stock units were acquired. |
| 02/01/2025 | Vesting date for the restricted stock units. |
| 02/14/2024 | Date the form was signed. |
Keywords
Eli Lilly, Executive Share Acquisition, Restricted Stock Units, Insider Trading, Form 4, Alonzo Weems
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.